Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 424

1.

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.

Brand C, Greve B, Bölling T, Eich HT, Willich N, Harrach S, Hintelmann H, Lenz G, Mesters RM, Kessler T, Schliemann C, Berdel WE, Schwöppe C.

PLoS One. 2020 Feb 21;15(2):e0229271. doi: 10.1371/journal.pone.0229271. eCollection 2020.

2.

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.

Lenz G, Hawkes E, Verhoef G, Haioun C, Thye Lim S, Seog Heo D, Ardeshna K, Chong G, Haaber J, Shi W, Gorbatchevsky I, Lippert S, Hiemeyer F, Piraino P, Beckmann G, Peña C, Buvaylo V, Childs BH, Salles G.

Leukemia. 2020 Feb 14. doi: 10.1038/s41375-020-0743-y. [Epub ahead of print]

PMID:
32060403
3.

Purinergic Signaling in Glioma Progression.

Braganhol E, Wink MR, Lenz G, Battastini AMO.

Adv Exp Med Biol. 2020;1202:87-108. doi: 10.1007/978-3-030-30651-9_5. Review.

PMID:
32034710
4.

[Current diagnostic and therapeutic standards in aggressive B-cell lymphomas].

Friedrichs B, Schmitz N, Lenz G.

Dtsch Med Wochenschr. 2020 Feb;145(3):151-154. doi: 10.1055/a-0949-4745. Epub 2020 Feb 4. German.

PMID:
32018287
5.

Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.

Wethmar K, Matern S, Eßeling E, Angenendt L, Pfeifer H, Brüggemann M, Stelmach P, Call S, Albring JC, Mikesch JH, Reicherts C, Groth C, Schliemann C, Berdel WE, Lenz G, Stelljes M.

Bone Marrow Transplant. 2020 Jan 30. doi: 10.1038/s41409-020-0801-0. [Epub ahead of print]

PMID:
32001801
6.

Tannic Acid Ameliorates STZ-Induced Alzheimer's Disease-Like Impairment of Memory, Neuroinflammation, Neuronal Death and Modulates Akt Expression.

Gerzson MFB, Bona NP, Soares MSP, Teixeira FC, Rahmeier FL, Carvalho FB, da Cruz Fernandes M, Onzi G, Lenz G, Gonçales RA, Spanevello RM, Stefanello FM.

Neurotox Res. 2020 Jan 29. doi: 10.1007/s12640-020-00167-3. [Epub ahead of print]

PMID:
31997154
7.

Lymphoma angiogenesis is orchestrated by noncanonical signaling pathways.

Gloger M, Menzel L, Grau M, Vion AC, Anagnostopoulos I, Zapukhlyak M, Gerlach K, Kammertöns T, Hehlgans T, Zschummel M, Lenz G, Gerhardt H, Höpken UE, Rehm A.

Cancer Res. 2020 Jan 13. pii: canres.1493.2019. doi: 10.1158/0008-5472.CAN-19-1493. [Epub ahead of print]

PMID:
31932457
8.

Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study.

Dreyling M, Santoro A, Mollica L, Leppä S, Follows G, Lenz G, Kim WS, Nagler A, Dimou M, Demeter J, Özcan M, Kosinova M, Bouabdallah K, Morschhauser F, Stevens DA, Trevarthen D, Munoz J, Rodrigues L, Hiemeyer F, Miriyala A, Garcia-Vargas J, Childs BH, Zinzani PL.

Am J Hematol. 2019 Dec 23. doi: 10.1002/ajh.25711. [Epub ahead of print]

PMID:
31868245
9.

Preclinical evaluation of a novel SHIP1 phosphatase activator for inhibition of PI3K signaling in malignant B-cells.

Lemm EA, Valle-Argos B, Smith LD, Richter J, Gebreselassie Y, Carter MJ, Karolova J, Svaton M, Helman K, Weston-Bell NJ, Karydis L, Williamson CT, Lenz G, Pettigrew J, Harwig C, Stevenson FK, Cragg M, Forconi F, Steele AJ, Cross J, Mackenzie L, Klener P, Packham G.

Clin Cancer Res. 2019 Dec 12. pii: clincanres.2202.2019. doi: 10.1158/1078-0432.CCR-19-2202. [Epub ahead of print]

PMID:
31831562
10.

Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.

Vessoni AT, Filippi-Chiela EC, Lenz G, Batista LFZ.

Oncogene. 2019 Dec 4. doi: 10.1038/s41388-019-1128-4. [Epub ahead of print] Review.

PMID:
31801972
11.

Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma.

Bucher P, Erdmann T, Grondona P, Xu W, Schmitt A, Schürch C, Zapukhlyak M, Schönfeld C, Serfling E, Kramer D, Grau M, Klener P, Lengerke C, Schulze-Osthoff K, Lenz G, Hailfinger S.

Blood. 2020 Jan 9;135(2):121-132. doi: 10.1182/blood.2019001866.

PMID:
31794606
12.
13.

Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.

Elsayad K, Reinartz G, Oertel M, Rehn S, Eismann J, Scobioala S, Berssenbrügge H, Eter N, Weishaupt C, Schmidt HH, Friedrichs B, Grünewald I, Hartmann W, Lenz G, Wardelmann E, Willich N, Eich HT.

Strahlenther Onkol. 2020 Feb;196(2):117-125. doi: 10.1007/s00066-019-01538-2. Epub 2019 Nov 15.

PMID:
31732783
14.

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.

Bolen CR, Klanova M, Trneny M, Sehn LH, He J, Tong J, Paulson JN, Kim E, Vitolo U, Di Rocco A, Fingerle-Rowson G, Nielsen T, Lenz G, Oestergaard MZ.

Haematologica. 2019 Nov 14. pii: haematol.2019.227892. doi: 10.3324/haematol.2019.227892. [Epub ahead of print]

15.

Novel insights into the pathogenesis of molecular subtypes of diffuse large B-cell lymphoma and their clinical implications.

Frontzek F, Lenz G.

Expert Rev Clin Pharmacol. 2019 Nov;12(11):1059-1067. doi: 10.1080/17512433.2019.1683447. Epub 2019 Oct 23. Review.

PMID:
31645159
16.

MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.

Gehring T, Erdmann T, Rahm M, Graß C, Flatley A, O'Neill TJ, Woods S, Meininger I, Karayel O, Kutzner K, Grau M, Shinohara H, Lammens K, Feederle R, Hauck SM, Lenz G, Krappmann D.

Cell Rep. 2019 Oct 22;29(4):873-888.e10. doi: 10.1016/j.celrep.2019.09.040.

17.

Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.

Elsayad K, Kroeger K, Greve B, Moustakis C, Assaf C, Stadler R, Lenz G, Weishaupt C, Eich HT.

Strahlenther Onkol. 2020 Jan;196(1):77-84. doi: 10.1007/s00066-019-01517-7. Epub 2019 Oct 7.

PMID:
31591658
18.

Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphoma.

Wullenkord R, Friedrichs B, Erdmann T, Lenz G.

Expert Rev Hematol. 2019 Dec;12(12):1053-1062. doi: 10.1080/17474086.2019.1676716. Epub 2019 Oct 11.

PMID:
31583927
19.

Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation.

Thomé MP, Borde C, Larsen AK, Henriques JAP, Lenz G, Escargueil AE, Maréchal V.

Antiviral Res. 2019 Dec;172:104615. doi: 10.1016/j.antiviral.2019.104615. Epub 2019 Sep 30.

PMID:
31580916
20.

Extract from Aloysia polystachya Induces the Cell Death of Colorectal Cancer Stem Cells.

Soares Machado M, Palma A, Panelo LC, Paz LA, Rosa F, Lira MC, Azurmendi P, Rubio MF, Lenz G, Urtreger AJ, Costas MA.

Nutr Cancer. 2019 Oct 1:1-14. doi: 10.1080/01635581.2019.1669676. [Epub ahead of print]

PMID:
31573355
21.

The whole-genome landscape of Burkitt lymphoma subtypes.

Panea RI, Love CL, Shingleton JR, Reddy A, Bailey JA, Moormann AM, Otieno JA, Ong'echa JM, Oduor CI, Schroeder KMS, Masalu N, Chao NJ, Agajanian M, Major MB, Fedoriw Y, Richards KL, Rymkiewicz G, Miles RR, Alobeid B, Bhagat G, Flowers CR, Ondrejka SL, Hsi ED, Choi WWL, Au-Yeung RKH, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig MA, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus BC, Seshadri V, Kim SY, Gascoyne RD, Levy S, Mukhopadyay M, Dunson DB, Dave SS.

Blood. 2019 Nov 7;134(19):1598-1607. doi: 10.1182/blood.2019001880.

PMID:
31558468
22.

Islets from human donors with higher but not lower hemoglobin A1c levels respond to gastrin treatment in vitro.

Lenz A, Lenz G, Ku HT, Ferreri K, Kandeel F.

PLoS One. 2019 Aug 20;14(8):e0221456. doi: 10.1371/journal.pone.0221456. eCollection 2019.

23.

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Angenendt L, Röllig C, Montesinos P, Martínez-Cuadrón D, Barragan E, García R, Botella C, Martínez P, Ravandi F, Kadia T, Kantarjian HM, Cortes J, Juliusson G, Lazarevic V, Höglund M, Lehmann S, Recher C, Pigneux A, Bertoli S, Dumas PY, Dombret H, Preudhomme C, Micol JB, Terré C, Ráčil Z, Novák J, Žák P, Wei AH, Tiong IS, Wall M, Estey E, Shaw C, Exeler R, Wagenführ L, Stölzel F, Thiede C, Stelljes M, Lenz G, Mikesch JH, Serve H, Ehninger G, Berdel WE, Kramer M, Krug U, Schliemann C.

J Clin Oncol. 2019 Oct 10;37(29):2632-2642. doi: 10.1200/JCO.19.00416. Epub 2019 Aug 20.

PMID:
31430225
24.

Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach.

Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Iser IC, Lenz GS, de Oliveira FH, Venturin G, Greggio S, daCosta JC, Wink MR, Sevigny J, Stefani MA, Battastini AMO, Teixeira HF, Braganhol E.

Mol Neurobiol. 2020 Feb;57(2):635-649. doi: 10.1007/s12035-019-01730-6. Epub 2019 Aug 12.

PMID:
31407144
25.

Adipose-derived stromal cell secretome disrupts autophagy in glioblastoma.

Onzi GR, Faccioni JL, Pereira LC, Thomé MP, Bertoni APS, Buss JH, Fazolo T, Filippi-Chiela E, Wink MR, Lenz G.

J Mol Med (Berl). 2019 Oct;97(10):1491-1506. doi: 10.1007/s00109-019-01829-2. Epub 2019 Aug 10.

PMID:
31401659
26.

Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth.

Villodre ES, Felipe KB, Oyama MZ, Oliveira FH, Lopez PLDC, Solari C, Sevlever G, Guberman A, Lenz G.

Biochem Biophys Res Commun. 2019 Sep 17;517(2):324-329. doi: 10.1016/j.bbrc.2019.07.064. Epub 2019 Jul 25.

PMID:
31353083
27.

Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma.

Elsayad K, Stockmann D, Channaoui M, Scobioala S, Grajda A, Berssenbrügge H, Huss S, Moustakis C, Haverkamp U, Kleinheinz J, Lenz G, Wardelmann E, Eich HT.

In Vivo. 2019 Jul-Aug;33(4):1293-1300. doi: 10.21873/invivo.11602.

28.

Exogenous expression of caveolin-1 is sufficient for hepatic stellate cell activation.

Ilha M, Moraes KDS, Rohden F, Martins LAM, Borojevic R, Lenz G, Barbé-Tuana F, Guma FCR.

J Cell Biochem. 2019 Nov;120(11):19031-19043. doi: 10.1002/jcb.29226. Epub 2019 Jun 30.

PMID:
31257611
29.

Dipyridamole impairs autophagic flux and exerts antiproliferative activity on prostate cancer cells.

Thomé MP, Pereira LC, Onzi GR, Rohden F, Ilha M, Guma FT, Wink MR, Lenz G.

Exp Cell Res. 2019 Sep 1;382(1):111456. doi: 10.1016/j.yexcr.2019.06.001. Epub 2019 Jun 11.

PMID:
31194978
30.

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.

Angenendt L, Bormann E, Pabst C, Alla V, Görlich D, Braun L, Dohlich K, Schwöppe C, Bohlander SK, Arteaga MF, Wethmar K, Hartmann W, Angenendt A, Kessler T, Mesters RM, Stelljes M, Rothenberg-Thurley M, Spiekermann K, Hébert J, Sauvageau G, Valk PJM, Löwenberg B, Serve H, Müller-Tidow C, Lenz G, Wörmann BJ, Sauerland MC, Hiddemann W, Berdel WE, Krug U, Metzeler KH, Mikesch JH, Herold T, Schliemann C.

Leukemia. 2019 Dec;33(12):2830-2841. doi: 10.1038/s41375-019-0505-x. Epub 2019 Jun 10.

PMID:
31182782
31.

Characterization of soluble CD39 (SolCD39/NTPDase1) from PiggyBac nonviral system as a tool to control the nucleotides level.

Beckenkamp LR, Iser IC, Onzi GR, Fontoura DMSD, Bertoni APS, Sévigny J, Lenz G, Wink MR.

Biochem J. 2019 Jun 11;476(11):1637-1651. doi: 10.1042/BCJ20190040.

PMID:
31085558
32.

Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma.

Oertel M, Elsayad K, Kroeger KJ, Haverkamp U, Rudack C, Lenz G, Eich HT.

Radiat Oncol. 2019 Apr 15;14(1):63. doi: 10.1186/s13014-019-1265-5.

33.

PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.

Weber J, de la Rosa J, Grove CS, Schick M, Rad L, Baranov O, Strong A, Pfaus A, Friedrich MJ, Engleitner T, Lersch R, Öllinger R, Grau M, Menendez IG, Martella M, Kohlhofer U, Banerjee R, Turchaninova MA, Scherger A, Hoffman GJ, Hess J, Kuhn LB, Ammon T, Kim J, Schneider G, Unger K, Zimber-Strobl U, Heikenwälder M, Schmidt-Supprian M, Yang F, Saur D, Liu P, Steiger K, Chudakov DM, Lenz G, Quintanilla-Martinez L, Keller U, Vassiliou GS, Cadiñanos J, Bradley A, Rad R.

Nat Commun. 2019 Mar 29;10(1):1415. doi: 10.1038/s41467-019-09180-3.

34.

Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophils.

Fischer J, Walter C, Tönges A, Aleth H, Jordão MJC, Leddin M, Gröning V, Erdmann T, Lenz G, Roth J, Vogl T, Prinz M, Dugas M, Jacobsen ID, Rosenbauer F.

Nat Immunol. 2019 May;20(5):546-558. doi: 10.1038/s41590-019-0343-z. Epub 2019 Mar 25.

PMID:
30911105
35.

Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML).

Kessler T, Koschmieder S, Schliemann C, Crysandt M, Mikesch JH, von Stillfried S, Stelljes M, Pohlen M, Lenz G, Kirsch A, Vehring K, Wardelmann E, Hartmann W, Bormann E, Gerss J, Brümmendorf TH, Müller-Tidow C, Berdel WE.

Ann Hematol. 2019 Jun;98(6):1393-1401. doi: 10.1007/s00277-019-03651-9. Epub 2019 Mar 21.

PMID:
30903275
36.

Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas.

Gonçalves RM, Agnes JP, Delgobo M, de Souza PO, Thomé MP, Heimfarth L, Lenz G, Moreira JCF, Zanotto-Filho A.

Biochem Pharmacol. 2019 May;163:440-450. doi: 10.1016/j.bcp.2019.03.015. Epub 2019 Mar 13.

PMID:
30878553
37.

Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).

Reinartz G, Pyra RP, Lenz G, Liersch R, Stüben G, Micke O, Willborn K, Hess CF, Probst A, Fietkau R, Jany R, Schultze J, Rübe C, Hirt C, Fischbach W, Bentz M, Daum S, Pott C, Tiemann M, Möller P, Neubauer A, Wilhelm M, Willich N, Berdel WE, Eich HT.

Strahlenther Onkol. 2019 Jun;195(6):544-557. doi: 10.1007/s00066-019-01446-5. Epub 2019 Mar 11.

PMID:
30859254
38.

Nuclear morphometric analysis in tissue as an objective tool with potential use to improve melanoma staging.

Nunes TWN, Filippi-Chiela EC, Callegari-Jacques SM, da Silva VD, Sansonowicz T, Lenz G, Roehe AV.

Melanoma Res. 2019 Oct;29(5):474-482. doi: 10.1097/CMR.0000000000000594.

PMID:
30839356
39.

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.

Cheson BD, O'Brien S, Ewer MS, Goncalves MD, Farooki A, Lenz G, Yu A, Fisher RI, Zinzani PL, Dreyling M.

Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):135-141. doi: 10.1016/j.clml.2018.11.021. Epub 2018 Nov 29.

40.

esiCancer: Evolutionary In Silico Cancer Simulator.

Minussi DC, Henz B, Dos Santos Oliveira M, Filippi-Chiela EC, Oliveira MM, Lenz G.

Cancer Res. 2019 Mar 1;79(5):1010-1013. doi: 10.1158/0008-5472.CAN-17-3924. Epub 2018 Dec 18.

PMID:
30563892
41.

Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.

Avanes A, Lenz G, Momand J.

Biochem Pharmacol. 2019 Feb;160:71-79. doi: 10.1016/j.bcp.2018.12.008. Epub 2018 Dec 12. Review.

42.

Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.

Friedrichs B, Nickelsen M, Ziepert M, Altmann B, Haenel M, Viardot A, Schmidt C, Ruebe C, Loeffler M, Pfreundschuh M, Rosenwald A, Glass B, Lenz G, Schmitz N; German high-grade lymphoma Study Group.

Br J Haematol. 2019 Mar;184(5):760-768. doi: 10.1111/bjh.15710. Epub 2018 Dec 5.

PMID:
30520013
43.

Chromatin conformation analysis of primary patient tissue using a low input Hi-C method.

Díaz N, Kruse K, Erdmann T, Staiger AM, Ott G, Lenz G, Vaquerizas JM.

Nat Commun. 2018 Nov 29;9(1):4938. doi: 10.1038/s41467-018-06961-0.

44.

EMT-like process in glioblastomas and reactive astrocytes.

Iser IC, Lenz G, Wink MR.

Neurochem Int. 2019 Jan;122:139-143. doi: 10.1016/j.neuint.2018.11.016. Epub 2018 Nov 26.

PMID:
30496766
45.

Temporal autoregulation during human PU.1 locus SubTAD formation.

Schuetzmann D, Walter C, van Riel B, Kruse S, König T, Erdmann T, Tönges A, Bindels E, Weilemann A, Gebhard C, Wethmar K, Perrod C, Minderjahn J, Rehli M, Delwel R, Lenz G, Gröschel S, Dugas M, Rosenbauer F.

Blood. 2018 Dec 20;132(25):2643-2655. doi: 10.1182/blood-2018-02-834721. Epub 2018 Oct 12.

PMID:
30315124
46.

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.

Kessler T, Baumeier A, Brand C, Grau M, Angenendt L, Harrach S, Stalmann U, Schmidt LH, Gosheger G, Hardes J, Andreou D, Dreischalück J, Lenz G, Wardelmann E, Mesters RM, Schwöppe C, Berdel WE, Hartmann W, Schliemann C.

Transl Oncol. 2018 Dec;11(6):1271-1282. doi: 10.1016/j.tranon.2018.08.004. Epub 2018 Aug 17.

47.

FHIRChain: Applying Blockchain to Securely and Scalably Share Clinical Data.

Zhang P, White J, Schmidt DC, Lenz G, Rosenbloom ST.

Comput Struct Biotechnol J. 2018 Jul 29;16:267-278. doi: 10.1016/j.csbj.2018.07.004. eCollection 2018.

48.

A Suite of Transgenic Driver and Reporter Mouse Lines with Enhanced Brain-Cell-Type Targeting and Functionality.

Daigle TL, Madisen L, Hage TA, Valley MT, Knoblich U, Larsen RS, Takeno MM, Huang L, Gu H, Larsen R, Mills M, Bosma-Moody A, Siverts LA, Walker M, Graybuck LT, Yao Z, Fong O, Nguyen TN, Garren E, Lenz GH, Chavarha M, Pendergraft J, Harrington J, Hirokawa KE, Harris JA, Nicovich PR, McGraw MJ, Ollerenshaw DR, Smith KA, Baker CA, Ting JT, Sunkin SM, Lecoq J, Lin MZ, Boyden ES, Murphy GJ, da Costa NM, Waters J, Li L, Tasic B, Zeng H.

Cell. 2018 Jul 12;174(2):465-480.e22. doi: 10.1016/j.cell.2018.06.035.

49.

90 Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experience.

Spukti EU, Schmidt LH, Schulze A, Schliemann C, Görlich D, Wardelmann E, Hartmann W, Lenz G, Berdel WE, Kerkhoff A.

Eur J Haematol. 2018 Oct;101(4):514-521. doi: 10.1111/ejh.13138. Epub 2018 Sep 3.

PMID:
29993147
50.

Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.

Pereira MB, Barros LRC, Bracco PA, Vigo A, Boroni M, Bonamino MH, Lenz G.

Oncoimmunology. 2018 Feb 12;7(6):e1431083. doi: 10.1080/2162402X.2018.1431083. eCollection 2018.

Supplemental Content

Support Center